For policy makers considering RDTs, this review aims to evaluate whether introducing RDTs into clinical algorithms improves patient health outcomes, and reduces the unnecessary overuse of anti-malarials. For health workers, this review also aims to evaluate the safety of withholding anti-malarials from people with a negative RDT.